Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ippei Iwatani"'
Autor:
Soichiro Morita, Masato Kasuga, Gen Yoshino, Tsutomu Kazumi, Makoto Tateiwa, Ippei Iwatani, Yoshihiko Ishida
Publikováno v:
Diabetes Research and Clinical Practice. 27:61-68
This study reports the result of a 12-month, open-label multicenter study of the efficacy and tolerability of pravastatin in the management of hypercholesterolemia associated with non-insulin-dependent diabetes mellitus. Pravastatin produced a decrea
Autor:
Fujio Numano, Ippei Iwatani, Shigeaki Baba, Masahide Iwai, Tsutomu Kazumi, Toshio Kasama, Kohji Matsuba, Masayuki Matsushita, Tomoyoshi Hosokawa, Gen Yoshino
Publikováno v:
Metabolism. 40:962-966
Effects of dietary carbohydrate on the secretion rate and particle size of triglyceride-rich lipoproteins were examined in Zucker fatty rats fed fructose and glucose and were compared with those of Zucker lean rats. Carbohydrates were supplied as 10%
Autor:
Kohji Matsuba, Shigeaki Baba, Toshio Kasama, Muneyoshi Yoshida, Gen Yoshino, Tsutomu Kazumi, Ippei Iwatani, Masahide Iwai, Masayuki Matsushita
Publikováno v:
Diabetes Research and Clinical Practice. 9:163-168
Long-term effects of bezafibrate on in vivo production of VLDL-triglyceride were studied in the rat. Bezafibrate given at a daily dose of 30 mg/kg body weight for 14 days produced a decrease not only in triglyceride by 51% but in cholesterol by 28% a
Autor:
Makoto Otsuki, Gen Yoshino, Tsutomu Kazumi, Ippei Iwatani, Shigeaki Baba, Masahide Iwai, Toshio Kasama, Kohji Matsuba, Masayuki Matsushita
Publikováno v:
Atherosclerosis. 71:95-101
The effect of CS-514 (eptastatin, Sankyo Co., Tokyo), a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, was investigated in 47 patients with hypercholesterolemia (WHO type IIa: 27, IIb: 20). Ten or 20 mg of CS-514 was admini
Publikováno v:
The Journal of Japan Atherosclerosis Society. 15:163-169
Autor:
Ippei Iwatani, Gen Yoshino, Shigeaki Baha, Kohji Matsuba, Masahide Iwai, Tsutomu Kazumi, Muneyoshi Yoshida, Munetaka Morita, Masayuki Matsushita
Publikováno v:
Diabetes Research and Clinical Practice. 7:313-316
The diabetogenic action of alloxan is known to be attenuated by several oxygen radical scavengers. The present study was conducted to see if probucol, a drug with strong free radical scavenger action, can reduce pancreatic B-cell damage induced by al
Autor:
Akio Inui, Toshio Kasama, Gen Yoshino, Kohji Matsuba, Shigeaki Baba, Masahide Iwai, Makoto Otsuki, Ippei Iwatani, Rinzo Uenoyama, Tsutomu Kazumi, Koichi Yokono
Publikováno v:
The Journal of Japan Atherosclerosis Society. 16:105-109
Autor:
Ippei Iwatani, Shigeaki Baba, Masahide Iwai, Gen Yoshino, Masayuki Matsushita, Tsutomu Kazumi, Kohji Matsuba, Munetaka Morita
Publikováno v:
Diabetes Research and Clinical Practice. 7:S115-S118
Exogenously induced hyperinsulinemia can increase in vivo triglyceride production in rats receiving dietary fructose, either as monosaccharide or as sucrose, but not in those receiving only glucose. Thus, in the presence of fructose, but not glucose,
Autor:
Yuki Yamashiro, Toru Oka, Shinya Hashimoto, Noboru Kobayashi, Shozo Miki, Yoshikazu Fujita, Ippei Iwatani, Tadayasu Shono, Takeo Goto
Publikováno v:
Journal of Japanese Society for Dialysis Therapy. 18:349-354
今回, 著者らは腎不全状態における脂質代謝異常について血中Apo A1, A2, Eを中心に, その他の脂質分画の1回の血液透析前後における変動および合併症の有無による差異等について検索を試
Autor:
Gen Yoshino, Ippei Iwatani, Shigeaki Baba, Masahide Iwai, Tsutomu Kazumi, Toshio Kasama, Kohji Matsuba
Publikováno v:
The Journal of Japan Atherosclerosis Society. 15:97-102